Scarica l'app Stockscreener
17.38
3.58%
0.60
Precedente Chiudi:
$16.78
Aprire:
$17
Volume 24 ore:
805.61K
Relative Volume:
1.53
Capitalizzazione di mercato:
$1.05B
Reddito:
$1.23M
Utile/perdita netta:
$-214.90M
Rapporto P/E:
-4.2162
EPS:
-4.1222
Flusso di cassa netto:
$-151.25M
1 W Prestazione:
+2.54%
1M Prestazione:
+5.40%
6M Prestazione:
-18.37%
1 anno Prestazione:
-29.81%
Intervallo 1D:
$16.77
$17.80
Intervallo di 1 settimana:
$15.73
$17.80
Portata 52W:
$10.91
$40.26
Spyre Therapeutics Inc Stock (SYRE) Company Profile
Nome
Spyre Therapeutics Inc
Settore
Industria
Telefono
(617) 651-5940
Indirizzo
221 CRESCENT STREET, WALTHAM
Confronta SYRE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SYRE
Spyre Therapeutics Inc
|
17.38 | 1.02B | 1.23M | -214.90M | -151.25M | -4.1222 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Spyre Therapeutics Inc Stock (SYRE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-08 | Iniziato | Leerink Partners | Outperform |
| 2025-03-18 | Iniziato | Wolfe Research | Outperform |
| 2024-09-04 | Iniziato | Wedbush | Outperform |
| 2024-07-16 | Iniziato | Evercore ISI | Outperform |
| 2024-05-02 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-01 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-20 | Iniziato | BTIG Research | Buy |
| 2023-12-11 | Iniziato | Guggenheim | Buy |
| 2023-12-11 | Iniziato | Jefferies | Buy |
| 2020-05-04 | Iniziato | Piper Sandler | Overweight |
| 2019-03-21 | Iniziato | JP Morgan | Overweight |
| 2018-09-04 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2018-04-24 | Iniziato | Evercore ISI | Outperform |
| 2018-03-14 | Reiterato | Needham | Buy |
Mostra tutto
Spyre Therapeutics Inc Borsa (SYRE) Ultime notizie
When is the best time to exit Spyre Therapeutics Inc.Market Performance Summary & Advanced Technical Signal Analysis - Newser
Analyzing net buyer seller activity in Spyre Therapeutics Inc.July 2025 Sector Moves & Fast Entry and Exit Trade Plans - Newser
Spyre Therapeutics Inc. stock trend forecastGDP Growth & Pattern Based Trade Signal System - Newser
Is it time to cut losses on Spyre Therapeutics Inc.July 2025 Outlook & Community Supported Trade Ideas - Newser
Relative strength of Spyre Therapeutics Inc. in sector analysisJuly 2025 Institutional & Safe Investment Capital Preservation Plans - Newser
What technical models suggest about Spyre Therapeutics Inc.’s comebackWeekly Market Report & AI Enhanced Trade Execution Alerts - Newser
Long term hold vs stop loss in Spyre Therapeutics Inc.Weekly Volume Report & Verified Stock Trade Ideas - Newser
How to build a dashboard for Spyre Therapeutics Inc. stock2025 Historical Comparison & Accurate Intraday Trade Tips - Newser
Can Spyre Therapeutics Inc. recover in the next quarterWeekly Trading Summary & AI Enhanced Trading Signals - Newser
RSI + MACD Show Convergence for Spyre Therapeutics Inc.2025 Valuation Update & Consistent Income Trade Ideas - newsyoung.net
Spyre Therapeutics Inc. stock retracement – recovery analysisPortfolio Value Report & Daily Stock Momentum Reports - Newser
Will Spyre Therapeutics Inc. bounce back from current supportWeekly Gains Summary & Real-Time Volume Spike Alerts - Newser
Spyre Therapeutics Inc. stock trend outlook and recovery path2025 Earnings Impact & Technical Pattern Recognition Alerts - Newser
Using AI based signals to follow Spyre Therapeutics Inc.2025 Technical Patterns & Weekly Return Optimization Plans - Newser
Combining machine learning predictions for Spyre Therapeutics Inc.July 2025 Institutional & Technical Confirmation Alerts - Newser
Spyre Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Trade Ideas & Proven Capital Preservation Methods - Newser
Will a bounce in Spyre Therapeutics Inc. offer an exitJuly 2025 Gainers & Real-Time Buy Zone Alerts - Newser
Is Spyre Therapeutics Inc. forming a bottoming basePortfolio Return Report & High Accuracy Swing Entry Alerts - Newser
How Spyre Therapeutics Inc. stock performs during market volatilityAnalyst Upgrade & Risk Adjusted Buy/Sell Alerts - Newser
What institutional flow reveals about Spyre Therapeutics Inc.Swing Trade & Weekly Top Performers Watchlists - Newser
What data driven models say about Spyre Therapeutics Inc.’s future2025 Volume Leaders & Weekly Return Optimization Alerts - Newser
Market reaction to Spyre Therapeutics Inc.’s recent newsTreasury Yields & Safe Swing Trade Setup Alerts - Newser
How hedge fund analytics apply to Spyre Therapeutics Inc. stockMarket Risk Analysis & Real-Time Volume Trigger Notifications - Newser
Can momentum traders help lift Spyre Therapeutics Inc.Quarterly Earnings Report & High Conviction Buy Zone Alerts - Newser
Published on: 2025-08-17 19:42:26 - classian.co.kr
Analyzing drawdowns of Spyre Therapeutics Inc. with statistical toolsPortfolio Risk Summary & Daily Entry Point Alerts - Newser
What’s the recovery path for long term holders of Spyre Therapeutics Inc.July 2025 Selloffs & Fast Entry and Exit Trade Plans - Newser
Traders Consider Averaging Down in Spyre Therapeutics Inc.Weekly Trend Summary & Growth Focused Investment Plans - metal.it
What moving averages say about Spyre Therapeutics Inc.July 2025 Snapshot & High Accuracy Trade Alerts - Newser
Published on: 2025-08-16 20:24:41 - Newser
Real time scanner hits for Spyre Therapeutics Inc. explainedEntry Point & AI Powered Market Entry Ideas - Newser
Why Spyre Therapeutics Inc. stock attracts strong analyst attentionPortfolio Risk Summary & Risk Controlled Daily Trade Plans - Newser
Spyre Therapeutics Inc Azioni (SYRE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Spyre Therapeutics Inc Azioni (SYRE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Albers Jeffrey W. | Director |
Oct 25 '24 |
Sale |
36.43 |
300 |
10,929 |
34,060 |
0.94%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):